Humanistic and Economic Burden of Geographic Atrophy: A Systematic Literature Review

References

• Sacconi R, Corbelli E, Querques L, Bandello F, Querques G. A review of current and future management of geographic atrophy. Ophthalmol Ther. 2017;6(1):69–77. doi:10.1007/s40123-017-0086-6
   PubMed Web of Science ®Google Scholar
• Fleckenstein M, Mitchell P, Freund KB, et al. The progression of geographic atrophy secondary to age-related macular degeneration. Ophthalmology. 2018;125(3):369–390. doi:10.1016/j.ophtha.2017.08.038
   PubMed Web of Science ®Google Scholar
• Chakravarthy U, Bailey CC, Scanlon PH, et al. Direct ophthalmic healthcare resource use among patients with geographic atrophy in a large cohort from the United Kingdom. Ophthalmol Retina. 2019;3(11):920–926. doi:10.1016/j.oret.2019.06.012
   Google Scholar
• Kim A, Shirneshan E, Campbell J, Devine B, Bansal A. Characterizing the healthcare resource utilization and costs in patients with geographic atrophy secondary to age-related macular degeneration stratified by disease severity (poster). Presented at the Virtual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research; May 18–20; 2020.
   Google Scholar
• Singh RP, Patel SS, Nielsen JS, Schmier JK, Rajput Y. Patient-, caregiver-, and eye care professional-reported burden of geographic atrophy secondary to age-related macular degeneration. Am J Ophthalmic Clin Trials. 2019;2(1):1–6. doi:10.25259/AJOCT-9-2018
   Google Scholar
• Rudnicka AR, Kapetanakis VV, Jarrar Z, et al. Incidence of late-stage age-related macular degeneration in American whites: systematic review and meta-analysis. Am J Ophthalmol. 2015;160(1):85–93.e3. doi:10.1016/j.ajo.2015.04.003
   PubMed Web of Science ®Google Scholar
• Lum F, Repka MX, Vicchrilli S. How to use the ICD-10 codes for age-related macular degeneration. EyeNet Magazine; 2017.
   Google Scholar
• Wright CB, Ambati J. Dry age-related macular degeneration pharmacology. Handb Exp Pharmacol. 2017;242:321–336.
   Google Scholar
• Nebbioso M, Lambiase A, Cerini A, Limoli PG, La Cava M, Greco A. Therapeutic approaches with intravitreal injections in geographic atrophy secondary to age-related macular degeneration: current drugs and potential molecules. Int J Mol Sci. 2019;20(7):1693. doi:10.3390/ijms20071693
   PubMed Web of Science ®Google Scholar
• Nielsen MK. Geographic atrophy. American Academy of Ophthalmology. EyeWiki; October 1, 2020. Available from: https://eyewiki.aao.org/Geographic_atrophy. Accessed October 19, 2020.
   Google Scholar
• OECD. Organization of economic co-operation and development; 2021. Available from: https://www.oecd.org/. Accessed November 15, 2021.
   Google Scholar
• Sivaprasad S, Tschosik E, Kapre A, et al. Reliability and construct validity of the NEI VFQ-25 in a subset of patients with geographic atrophy from the Phase 2 Mahalo Study. Am J Ophthalmol. 2018;190:1–8. doi:10.1016/j.ajo.2018.03.006
   PubMed Web of Science ®Google Scholar
• Marella M, Pesudovs K, Keeffe JE, O’Connor PM, Rees G, Lamoureux EL. The psychometric validity of the NEI VFQ-25 for use in a low-vision population. Invest Ophthalmol Vis Sci. 2010;51(6):2878–2884. doi:10.1167/iovs.09-4494
   PubMed Web of Science ®Google Scholar
• Steinberg EP, Tielsch JM, Schein OD, et al. The VF-14. An index of functional impairment in patients with cataract. Arch Ophthalmol. 1994;112(5):630–638. doi:10.1001/archopht.1994.01090170074026
   PubMedGoogle Scholar
• Mackenzie PJ, Chang TS, Scott IU, et al. Assessment of vision-related function in patients with age-related macular degeneration. Ophthalmology. 2002;109(4):720–729. doi:10.1016/S0161-6420(01)01021-1
   Web of Science ®Google Scholar
• Riusala A, Sarna S, Immonen I. Visual function index (VF-14) in exudative age-related macular degeneration of long duration. Am J Ophthalmol. 2003;135(2):206–212. doi:10.1016/S0002-9394(02)01832-9
   Web of Science ®Google Scholar
• Kimel M, Leidy NK, Tschosik E, et al. Functional Reading Independence (FRI) Index: a new patient-reported outcome measure for patients with geographic atrophy. Invest Ophthalmol Vis Sci. 2016;57(14):6298–6304. doi:10.1167/iovs.16-20361
   Web of Science ®Google Scholar
• Mehta H, Tufail A, Daien V, et al. Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors. Prog Retin Eye Res. 2018;65:127–146. doi:10.1016/j.preteyeres.2017.12.002
   PubMed Web of Science ®Google Scholar
• Rodrigues IA, Sprinkhuizen SM, Barthelmes D, et al. Defining a minimum set of standardized patient-centered outcome measures for macular degeneration. Am J Ophthalmol. 2016;168:1–12. doi:10.1016/j.ajo.2016.04.012
   Web of Science ®Google Scholar
• Patnaik JL, Lynch AM, Pecen PE, et al. The impact of advanced age-related macular degeneration on the National Eye Institute’s Visual Function Questionnaire-25. Acta Ophthalmol. 2020. doi:10.1111/aos.14731
   Web of Science ®Google Scholar
• Burguera-Giménez N, García-Lázaro S, España-Gregori E, et al. Multimodal evaluation of visual function in geographic atrophy versus normal eyes. Clin Ophthalmol. 2020;14:1533–1545. doi:10.2147/OPTH.S246245
   PubMed Web of Science ®Google Scholar
• Patel PJ, Ziemssen F, Ng E, et al. Burden of illness in geographic atrophy: a study of vision-related quality of life and health care resource use. Clin Ophthalmol. 2020;14:15–28. doi:10.2147/OPTH.S226425
   Web of Science ®Google Scholar
• Ahluwalia A, Shen LL, Del Priore LV. Central geographic atrophy vs. neovascular age-related macular degeneration: differences in longitudinal vision-related quality of life. Graefes Arch Clin Exp Ophthalmol. 2021;259(2):307–316. doi:10.1007/s00417-020-04892-5
   PubMed Web of Science ®Google Scholar
• Ahluwalia A, Shen LL, Del Priore LV. Natural history of vision-related quality of life in advanced age-related macular degeneration. Invest Ophthalmol Vis Sci. 2020;61(7):1937.
   Web of Science ®Google Scholar
• Sivaprasad S, Tschosik EA, Guymer RH, et al. Living with geographic atrophy: an ethnographic study. Ophthalmol Ther. 2019;8(1):115–124. doi:10.1007/s40123-019-0160-3
   PubMed Web of Science ®Google Scholar
• Chakravarthy U, Bailey CC, Johnston RL, et al. Characterizing disease burden and progression of geographic atrophy secondary to age-related macular degeneration. Ophthalmology. 2018;125(6):842–849. doi:10.1016/j.ophtha.2017.11.036
   PubMed Web of Science ®Google Scholar
• Carlton J, Barnes S, Haywood A. Patient perspectives in geographic atrophy (GA): exploratory qualitative research to understand the impact of GA for patients and their families. Br Ir Orthopt J. 2019;15(1):133–141. doi:10.22599/bioj.137
   Google Scholar
• Borkenstein AF, Borkenstein EM. Four years of observation to evaluate autonomy and quality of life after implantation of a high-add intraocular lens in age-related macular degeneration patients. Case Rep Ophthalmol. 2020;11(2):448–456. doi:10.1159/000508914
   Web of Science ®Google Scholar
• Rohart C, Fajnkuchen F, Nghiem-Buffet S, Abitbol O, Badelon I, Chaine G. [Cataract surgery and age-related maculopathy: benefits in terms of visual acuity and quality of life–a prospective study] Chirurgie de la cataracte et degenerescence maculaire liee a l’age: benefice en termes d’acuite visuelle et de qualite de vie–etude prospective. J Fr Ophtalmol. 2008;31(6 Pt 1):571–577. doi:10.1016/s0181-5512(08)75457-3
   Web of Science ®Google Scholar
• Higgins BE, Taylor DJ, Bi W, Binns AM, Crabb DP. Novel computer-based assessments of everyday visual function in people with age-related macular degeneration. PLoS One. 2020;15(12):e0243578. doi:10.1371/journal.pone.0243578
   PubMed Web of Science ®Google Scholar
• Sunness JS, Rubin GS, Zuckerbrod A, Applegate CA. Foveal-sparing scotomas in advanced dry age-related macular degeneration. J Vis Impair Blind. 2008;102(10):600–610. doi:10.1177/0145482X0810201004
   Web of Science ®Google Scholar
• Sunness JS, Rubin GS, Broman A, Applegate CA, Bressler NM, Hawkins BS. Low luminance visual dysfunction as a predictor of subsequent visual acuity loss from geographic atrophy in age-related macular degeneration. Ophthalmology. 2008;115(9):1480–8, 8 e1–2. doi:10.1016/j.ophtha.2008.03.009
   PubMed Web of Science ®Google Scholar
• Rovner BW, Casten RJ, Tasman WS. Effect of depression on vision function in age-related macular degeneration. Arch Ophthalmol. 2002;120(8):1041–1044. doi:10.1001/archopht.120.8.1041
   PubMed Web of Science ®Google Scholar
• Kim A. Characterizing the healthcare resource utilization and costs by disease severity among patients with geographic atrophy secondary to age-related macular degeneration. ResearchWorks Archive; 2019. Available from: https://digital.lib.washington.edu/researchworks/handle/1773/44687. Accessed November 19, 2021.
   Google Scholar
• Anastasopoulos E, Yu F, Coleman AL. Age-related macular degeneration is associated with an increased risk of hip fractures in the Medicare database. Am J Ophthalmol. 2006;142(6):1081–1083. doi:10.1016/j.ajo.2006.06.058
   Web of Science ®Google Scholar
• Lotery A, Xu X, Zlatava G, Loftus J. Burden of illness, visual impairment and health resource utilisation of patients with neovascular age-related macular degeneration: results from the UK cohort of a five-country cross-sectional study. Br J Ophthalmol. 2007;91(10):1303–1307. doi:10.1136/bjo.2007.116939
   PubMed Web of Science ®Google Scholar
• Brown MM, Brown GC, Stein JD, Roth Z, Campanella J, Beauchamp GR. Age-related macular degeneration: economic burden and value-based medicine analysis. Can J Ophthalmol. 2005;40(3):277–287. doi:10.1016/S0008-4182(05)80070-5
   Web of Science ®Google Scholar
• Künzel SH, Möller PT, Lindner M, et al. Determinants of quality of life in geographic atrophy secondary to age-related macular degeneration. Invest Ophthalmol Vis Sci. 2020;61(5):63. doi:10.1167/iovs.61.5.63
   Web of Science ®Google Scholar
• Orr SC, Pierson R, Bogert J, et al. Disease burden associated with geographic atrophy secondary to age-related macular degeneration. Invest Ophthalmol Vis Sci. 2016;57(12):21.
   Web of Science ®Google Scholar
• Patnaik J, Pecen P, Lynch A, Siringo F, Mathias M, Mandava N. The National Eye Institute Visual Function Questionnaire-25 in patients with age-related macular degeneration and controls. Invest Ophthalmol Vis Sci. 2019;60(9):67.
   Web of Science ®Google Scholar
• Wang F, Fries M, Wurzelmann JI, et al. Patient-reported visual function in patients with geographic atrophy secondary to age-related macular degeneration (AMD): baseline characteristics of the BAM114341 cohort. Invest Ophthalmol Vis Sci. 2015;56(7):2811. doi:10.1167/iovs.14-16009
   Web of Science ®Google Scholar